Shree Ganesh Remedies Limited (BSE: 540737)
Health Care · Pharmaceuticals · IN
Rs681.25
-1.72% today · +35.7% 1Y
Shree Ganesh Remedies Limited (BSE: 540737) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $90.37M.
Over the last twelve months the share price has gained 35.7%, trading between 381.10 and 759.00.
Tweenvest scores Shree Ganesh Remedies Limited across four factors: quality 75/100, value 8/100, growth 76/100. Its strongest factor is growth.
540737 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $90.37M
- Revenue (TTM)
- $10.47M
- P/E
- 56.70
- EPS
- 12.01
- Dividend yield
- —
- Beta (5Y)
- 0.51
- 52-week high
- Rs759.00
- 52-week low
- Rs381.10
- Avg volume (3M)
- —
- Shares outstanding
- 12.84M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PT Merck TbkIDX: MERK | $93.89M | Rp3,750.00 | -1.06% |
| AlzeCure Pharma AB (publ)OM: ALZCUR | $93.23M | Skr7.10 | +5.03% |
| Rani Therapeutics Holdings, Inc.NasdaqGM: RANI | $92.22M | $0.76 | -5.26% |
| Stella Pharma CorporationTSE: 4888 | $92.15M | ¥394.00 | -7.51% |
| Renascience Inc.TSE: 4889 | $89.79M | ¥1,032.00 | -6.44% |
| Dong Sung Bio Pharm.Co.,Ltd.KOSE: A002210 | $89.60M | ₩1,283.00 | +0.39% |
| Neumora Therapeutics, Inc.NasdaqGS: NMRA | $89.38M | $0.44 | -8.05% |
| Dar Al Dawa Development and Investment Co. Ltd.ASE: DADI | $88.16M | JD1.25 | +1.63% |
Figures last refreshed Oct 11, 2026.